D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $132B
1-Year Est. Return 38.69%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+38.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$132B
AUM Growth
+$7.59B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,643
New
Increased
Reduced
Closed

Top Buys

1 +$1.52B
2 +$1.43B
3 +$798M
4
AMZN icon
Amazon
AMZN
+$646M
5
TXN icon
Texas Instruments
TXN
+$619M

Top Sells

1 +$1.31B
2 +$1.01B
3 +$863M
4
WDC icon
Western Digital
WDC
+$595M
5
META icon
Meta Platforms (Facebook)
META
+$591M

Sector Composition

1 Technology 25.89%
2 Consumer Discretionary 12.56%
3 Healthcare 10.57%
4 Industrials 9.86%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTZ icon
401
MasTec
MTZ
$22.9B
$51.9M 0.04%
238,882
+48,014
MDGL icon
402
Madrigal Pharmaceuticals
MDGL
$10.1B
$51.6M 0.04%
88,554
-7,628
XYL icon
403
Xylem
XYL
$29.1B
$51.4M 0.04%
377,246
-273,434
GNW icon
404
Genworth Financial
GNW
$3.11B
$51.3M 0.04%
5,680,337
-809,512
KNSA icon
405
Kiniksa Pharmaceuticals
KNSA
$3.5B
$51.2M 0.04%
1,241,621
+107,435
MLI icon
406
Mueller Industries
MLI
$12.2B
$51.1M 0.04%
445,343
+168,715
AVPT icon
407
AvePoint
AVPT
$2.25B
$51M 0.04%
3,672,278
+2,271,522
EXAS icon
408
Exact Sciences
EXAS
$19.8B
$51M 0.04%
502,142
+481,379
FE icon
409
FirstEnergy
FE
$29.6B
$50.9M 0.04%
1,136,721
+46,657
RRX icon
410
Regal Rexnord
RRX
$12.4B
$50.8M 0.04%
362,209
+175,693
JMIA
411
Jumia Technologies
JMIA
$894M
$50.7M 0.04%
4,059,288
+185,064
XRAY icon
412
Dentsply Sirona
XRAY
$2.31B
$50.7M 0.04%
4,434,744
+1,537,885
SBSW icon
413
Sibanye-Stillwater
SBSW
$8.9B
$50.7M 0.04%
3,556,894
-2,618,834
TARS icon
414
Tarsus Pharmaceuticals
TARS
$2.89B
$50.4M 0.04%
615,156
+16,849
UBER icon
415
Uber
UBER
$151B
$50.2M 0.04%
614,315
+562,015
CUK icon
416
Carnival PLC
CUK
$31.3B
$50.1M 0.04%
1,650,551
+1,369,284
AGIO icon
417
Agios Pharmaceuticals
AGIO
$1.63B
$50M 0.04%
1,837,186
+1,469,437
NTAP icon
418
NetApp
NTAP
$19.5B
$49.9M 0.04%
465,893
+464,106
FNV icon
419
Franco-Nevada
FNV
$48.6B
$49.9M 0.04%
240,528
+127,386
MSTR icon
420
Strategy Inc
MSTR
$46.6B
$49.7M 0.04%
327,047
+273,267
CHKP icon
421
Check Point Software Technologies
CHKP
$16.5B
$49.5M 0.04%
266,589
+87,405
APD icon
422
Air Products & Chemicals
APD
$64.1B
$49.3M 0.04%
199,760
+198,593
CHD icon
423
Church & Dwight Co
CHD
$23.1B
$49.2M 0.04%
586,354
+271,963
SLB icon
424
SLB Ltd
SLB
$67.1B
$49.1M 0.04%
1,279,585
-174,909
VRRM icon
425
Verra Mobility
VRRM
$2.26B
$49M 0.04%
2,187,539
+1,159,951